These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3301165)

  • 1. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy.
    Leslie P; Jung RT; Isles TE; Baty J
    Clin Sci (Lond); 1987 Jul; 73(1):41-5. PubMed ID: 3301165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy expenditure in type 2 diabetic patients on metformin and sulphonylurea therapy.
    Chong PK; Jung RT; Rennie MJ; Scrimgeour CM
    Diabet Med; 1995 May; 12(5):401-8. PubMed ID: 7648802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin.
    Avignon A; Lapinski H; Rabasa-Lhoret R; Caubel C; Boniface H; Monnier L
    Diabetes Obes Metab; 2000 Aug; 2(4):229-35. PubMed ID: 11225656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type I diabetes mellitus.
    Leslie P; Jung RT; Isles TE; Baty J; Newton RW; Illingworth P
    Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1121-6. PubMed ID: 3094802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus.
    Groop L; Widén E; Franssila-Kallunki A; Ekstrand A; Saloranta C; Schalin C; Eriksson J
    Diabetologia; 1989 Aug; 32(8):599-605. PubMed ID: 2506091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.
    Welle S; Nair KS; Lockwood D
    J Clin Endocrinol Metab; 1988 Mar; 66(3):593-7. PubMed ID: 3127418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetice.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Horm Metab Res; 1979 May; 11(5):332-7. PubMed ID: 573232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermic effect of glucose in obese subjects with non-insulin-dependent diabetes mellitus.
    Ravussin E; Zawadzki JK
    Diabetes; 1987 Dec; 36(12):1441-7. PubMed ID: 3315790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Ravussin E; Bogardus C; Schwartz RS; Robbins DC; Wolfe RR; Horton ES; Danforth E; Sims EA
    J Clin Invest; 1983 Sep; 72(3):893-902. PubMed ID: 6350368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes.
    McAlpine LG; McAlpine CH; Waclawski ER; Storer AM; Kay JW; Frier BM
    Eur J Clin Pharmacol; 1988; 34(2):129-32. PubMed ID: 3289948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).
    Pratley RE; Urosevic D; Boldrin M; Balena R;
    Diabetes Obes Metab; 2013 Mar; 15(3):234-40. PubMed ID: 22958426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.
    Boyd K; Boreham C; Andrews WJ; Hadden DR
    Diabetes Res; 1991 Nov; 18(3):101-8. PubMed ID: 1841819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.
    Bannister CA; Holden SE; Jenkins-Jones S; Morgan CL; Halcox JP; Schernthaner G; Mukherjee J; Currie CJ
    Diabetes Obes Metab; 2014 Nov; 16(11):1165-73. PubMed ID: 25041462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of body weight during antidiabetic treatment].
    Hamann A
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S255-8. PubMed ID: 17139582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.